Artificial intelligence  in lung cancer: where are we now?

F. Gleeson (Oxford (Oxfordshire), United Kingdom)

Source: Virtual Congress 2020 – Imaging grand round
Session: Imaging grand round
Session type: Grand round
Number: 3749

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Gleeson (Oxford (Oxfordshire), United Kingdom). Artificial intelligence  in lung cancer: where are we now?. Virtual Congress 2020 – Imaging grand round

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ERS School Course Early-stage lung cancer - What's new in the epidemiology of lung cancer: the female aspect
Source: ISSN=ISSN 1810-6838, ISBN=, page=339
Year: 2006

The role of artificial intelligence in lung cancer screening
Source: Virtual Congress 2020 – Frontiers of lung cancer screening
Year: 2020


Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016


Artificial intelligence meets interstitial lung diseases
Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets?
Year: 2019


Single Slide Assessment: the future of molecular testing in lung cancer?
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017

Biomarkers in early-detection of lung cancer: current concepts
Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts
Year: 2021

Lung cancer: only tobacco-smoking?
Source: Annual Congress 2004 - Occupational Grand Round, an interactive session
Year: 2004

Lung cancer: what are the genetic and genomic perspectives?
Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management
Year: 2016


Lung cancer screening - what does it mean for our practice?
Source: Virtual Congress 2020 – Screening and imaging in lung cancer
Year: 2020




Lung cancer - are we ageist?
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy?
Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician
Year: 2010



Stem cells and lung cancer treatment: any hope?
Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management
Year: 2016


Complexity of diagnostics of complicated lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004

Surgery of lung cancer in elderly patients: lessons learned
Source: Annual Congress 2008 - Treatment of thoracic tumours
Year: 2008

Outcome after single lung transplantation: what about cancer of the native lung?
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009


Management of incidental nodules in lung cancer screening: ready for prime-time?
Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019
Year: 2019